SweetValueLab
Write for us

Johnson & Johnson — Financial Statements & Ratios

JNJ
NYSEHealthcareDrug Manufacturers - GeneralCIK 0000200406jnj.comAbout JNJ
Last close · Oct 16, 2026255.56+2.28 (+0.90%)
Market cap$615.9B

Key indicators

Revenue97.9BTTM+8.1% on a year earlier+2.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2021FY2022FY2023FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
81.6B 82.1B+0.6%82.6B+0.6%93.8B+13.6%94.9B+1.2%85.2B−10.3%88.8B+4.3%94.2B+6.0%97.9B+8.1%101.2B 108.2B 116.9B
— 0.6% 0.6% 13.6% 1.2% -10.3% 4.3% 6.0% 8.1% 7.5% 6.9% 8.1%
$5.61 $5.63+0.4%$5.51−2.1%$7.81+41.7%$6.73−13.8%$13.72+103.9%$5.79−57.8%$11.03+90.5%$8.61−7.9%$11.19 $11.85 $14.00
Profitability
66.8% 66.4%−0.4 pt65.6%−0.8 pt68.2%+2.6 pt67.3%−0.9 pt68.8%+1.6 pt69.1%+0.3 pt67.9%−1.2 pt67.9%−0.0 pt· · ·
18.8% 18.4%−0.3 pt17.8%−0.6 pt22.3%+4.4 pt18.9%−3.4 pt41.3%+22.4 pt15.8%−25.4 pt28.5%+12.6 pt21.5%−3.5 pt· · ·
Cash
18.5B 19.9B+7.5%20.2B+1.4%19.8B−2.1%17.2B−13.0%18.2B+6.2%19.8B+8.7%19.7B−0.7%22.2B+19.9%· · ·
22.7% 24.3%+1.6 pt24.4%+0.2 pt21.1%−3.4 pt18.1%−3.0 pt21.4%+3.3 pt22.3%+0.9 pt20.9%−1.4 pt22.7%+2.2 pt· · ·
Balance sheet
2.73B 2.68B−1.6%2.67B−0.5%2.67B+0.1%2.66B−0.4%2.56B−3.9%2.43B−5.1%2.43B+0.0%2.44B+0.9%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 28, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.